Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of intratumoral concentrations of kinase inhibitors in advanced solid tumors
NL-OMON36159Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Aug 2011
- Countries
- 1
01
Overview
Open-label trial in Nonhematologic neoplasms (7 cohorts), sponsored by Vrije University Medical Center. Primary endpoint: Intratumoral kinase inhibitor concentrations. Started Aug 2011; status: recruiting.
02
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on NL-OMON36159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36159.